Header
 
Login
 

Privatsphäre-Einstellungen

Wir verwenden Cookies auf unserer Website. Einige von ihnen sind unerlässlich, während andere uns helfen, diese Website und Ihre Erfahrungen zu verbessern.

Notwendig Statistik Marketing
Auswahl bestätigen
Weitere Einstellungen

Hier finden Sie eine Übersicht aller verwendeten Cookies. Sie können ganzen Kategorien Ihre Zustimmung geben oder weitere Informationen anzeigen und bestimmte Cookies auswählen.

Alle auswählen
Auswahl bestätigen
Notwendig Cookies
Wesentliche Cookies ermöglichen grundlegende Funktionen und sind für die ordnungsgemäße Funktion der Website erforderlich.
Statistik Cookies
Statistik-Cookies sammeln anonym Informationen. Diese Informationen helfen uns zu verstehen, wie unsere Besucher unsere Website nutzen.
Marketing Cookies
Marketing-Cookies werden von Werbekunden oder Publishern von Drittanbietern verwendet, um personalisierte Anzeigen zu schalten. Sie tun dies, indem sie Besucher über Websites hinweg verfolgen
Zurück

    Passive Kühlung von pharmazeutischem Transportgut

    Inwieweit können erhaltene Ergebnisse dazu genutzt werden, um allgemeingültige Aussagen zur Transportsicherheit zu machen?

    Michael Pfeiffer

    Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim/Rhein

    Korrespondenz: Dr. Michael Pfeiffer, Global Quality Services, Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Straße 173, 55216 Ingelheim/Rhein (Germany), e-mail: michael.pfeiffer@boehringer-ingelheim.com

    Passive Cooling in Pharmaceutical Transportation/Use of obtained results for the Assessment of Transport Safety

    Goods to be transported were kept at varying external temperature conditions within a pre-defined temperature “range” of (5 ± 3) °C by means of pre-cooled, 4 °C, thermal packs. From the results obtained, similarities were tried to derive with respect to similar behaviour of goods being exposed to different external temperature conditions. To recognize similarities might be important as with the Arzneimittel- und Wirkstoffherstellungsverordnung (ordinance on medicinal products and active pharmaceutical ingredients manufacture, AMWHV) coming into force in Germany end of 2006 it is expected by authorities, that the harmlessness of the transport with respect to the quality of the goods been transported has to be proven in all cases. As there are numerous factors, e. g. fall, collision, light intensity, temperature, realtive humidity etc. to be considered in the transport of goods, every single transport had – theoretically – to be assessed restrospectively for possible negative impact on these goods. As it is not possible to retrospectively assess each single transport, the investigations been published here were used for possible prospective predictions. As variable factor, “temperature” was chosen, as temperature might have a major influence on the goods during transport. Similarities could only be shown in a few cases and correlation could hardly be proven. As it is, despite of the results presented, furthermore not possible to retrospectively assess possible influences of each transport onto transported goods, additional investigations are to be performed. Whether these investigations are to be performed by the haulage- or by the pharmaceutical companies was not subject of this publication, and is further dependant on the content of the individual contract between pharmaceutical manufacturer and haulage company [3].

    Key words Influence of temperature on transport • Ordinance on medicinal products and active pharmaceutical ingredients manufacture (AMWHV) • Transport • Validation




    © ECV- Editio Cantor Verlag (Germany) 2011

     

    pharmind 2011, Nr. 3, Seite 582